Aveir VR Real-World Evidence Post-Approval Study

This study is collecting real-world data on patients who have received the Aveir VR leadless pacemaker — a small, self-contained pacemaker implanted directly into the heart without leads (wires). The study uses Medicare claims data to track long-term outcomes. You may be eligible if: - You have already been implanted with an Aveir VR leadless pacemaker - You are enrolled in Medicare Part A and Part B continuously for 12 months before and 30 days after the implant - Your data can be linked with Medicare fee-for-service records You may NOT be eligible if: - You do not have the required continuous Medicare enrollment - Your data cannot be linked to Medicare fee-for-service records Talk to your doctor to see if this trial is right for you.